Abstract
Objective
Pulsed dye laser has been proved to be fairly effective in the treatment of infantile hemangioma. But the effect varies in different body sites. The objective of this study was to assess the long-term outcome and complications of 595 nm pulsed dye laser in the treatment of hand infantile hemangioma in our laser department, retrospectively.
Patients and Methods
The patients with hand infantile hemangioma who had received pulsed dye laser (595 nmV-beam, Candela Cop., Wayland, MA. Parameters: fluence 10∼13 J/cm2, pulse duration 20∼40 ms, spot diameter 7 mm, epidermal cooling 20/40 s) treatment in past 5 years were recruited for the study. Detailed demographics, results of questionnaires and clinical examination were entered into a database and statistical analyses were conducted where applicable.
Results
43 patients with hand infantile hemangioma were recruited, including 29 females and 14 males, with a mean age of 8.92 months at treatment time. 7 patients with 10 hemangioma lesions at other sites from the hand meanwhile received laser treatment. There was a significant difference in the subjective assessment of clearing between hand lesions and additional other site hemangioma (p < 0.001). The average Patient Satisfaction Score was 7.25 for hand hemangioma, the average Patient Satisfaction Score was 4.45 for other site hemangioma lesions, there was a significant difference between hand and non-hand lesions (p < 0.001).
Conclusions
595 nm pulsed dye laser provides a safe and effective modality with lower morbidity for hand hemangioma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sidbury R. Update on vascular tumors of infancy. Curr Opin Pediatr 2010; 22: 432–437.
Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122: 360–367.
Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012; 2012: 645678. doi: 10.1155/2012/645678.
Fuchsmann C, Quintal MC, Giguere C, et al. Propranolol as firstline treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg 2011; 137: 471–478.
Tay YK, Tan SK. Treatment of infantile hemangiomas with the 595- nm pulsed dye laser using different pulse widths in an Asian population. Lasers Surg Med 2012; 44: 93–96.
Garden JM, Polla LL, Tan OT. The treatment of port-wine stains by the pulsed dye laser. Analysis of pulse duration and long-term therapy. Arch Dermatol 1988; 124: 889–896.
Batta K, Goodyear HM, Moss C, et al. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 2002, 17;360:521–527.
Chen W, Liu S, Yang C, Yang S. Clinical efficacy of the 595nm Pulsed Dye Laser in the treatment of Childhood Superficial Hemangioma-Analysis of 10-year Application in Chinese Patients. J Dermatolog Treat 2013 May 23. [Epub ahead of print].
Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol 1993; 129: 182–188.
Michel JL. Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol 2003; 13: 136–141.
Witman PM, Wagner AM, Scherer K, et al. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 2006; 38: 116–123.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chen, W., Yang, C., Liu, S. et al. Curative effect study of pulsed dye laser in the treatment of 43 patients with hand infantile hemangioma. Eur J Dermatol 24, 76–79 (2014). https://doi.org/10.1684/ejd.2013.2223
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2013.2223